BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24286825)

  • 21. E2F-dependent transcription of the raf proto-oncogene during Drosophila development.
    Kwon EJ; Oh EJ; Kim YS; Hirose F; Ohno K; Nishida Y; Matsukage A; Yamaguchi M; Yoo MA
    Nucleic Acids Res; 2001 Apr; 29(8):1808-14. PubMed ID: 11292854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E2F/Dp inactivation in fat body cells triggers systemic metabolic changes.
    Zappia MP; Guarner A; Kellie-Smith N; Rogers A; Morris R; Nicolay B; Boukhali M; Haas W; Dyson NJ; Frolov MV
    Elife; 2021 Jul; 10():. PubMed ID: 34251339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A genome-wide RNA interference screen identifies putative chromatin regulators essential for E2F repression.
    Lu J; Ruhf ML; Perrimon N; Leder P
    Proc Natl Acad Sci U S A; 2007 May; 104(22):9381-6. PubMed ID: 17517653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging links between E2F control and mitochondrial function.
    Benevolenskaya EV; Frolov MV
    Cancer Res; 2015 Feb; 75(4):619-23. PubMed ID: 25634216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integration of a growth-suppressing BTB/POZ domain protein with the DP component of the E2F transcription factor.
    de la Luna S; Allen KE; Mason SL; La Thangue NB
    EMBO J; 1999 Jan; 18(1):212-28. PubMed ID: 9878064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The transcription factor E2F is required for S phase during Drosophila embryogenesis.
    Duronio RJ; O'Farrell PH; Xie JE; Brook A; Dyson N
    Genes Dev; 1995 Jun; 9(12):1445-55. PubMed ID: 7601349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic enzyme IMPDH is also a transcription factor regulated by cellular state.
    Kozhevnikova EN; van der Knaap JA; Pindyurin AV; Ozgur Z; van Ijcken WF; Moshkin YM; Verrijzer CP
    Mol Cell; 2012 Jul; 47(1):133-9. PubMed ID: 22658723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular characterization of Xenopus laevis DP proteins.
    Girling R; Bandara LR; Ormondroyd E; Lam EW; Kotecha S; Mohun T; La Thangue NB
    Mol Biol Cell; 1994 Oct; 5(10):1081-92. PubMed ID: 7865876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RecQL4 regulates autophagy and apoptosis in U2OS cells.
    Duan Y; Fang H
    Biochem Cell Biol; 2016 Dec; 94(6):551-559. PubMed ID: 27813658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. E2F function in muscle growth is necessary and sufficient for viability in Drosophila.
    Zappia MP; Frolov MV
    Nat Commun; 2016 Jan; 7():10509. PubMed ID: 26823289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control of mitochondrial structure and function by the Yorkie/YAP oncogenic pathway.
    Nagaraj R; Gururaja-Rao S; Jones KT; Slattery M; Negre N; Braas D; Christofk H; White KP; Mann R; Banerjee U
    Genes Dev; 2012 Sep; 26(18):2027-37. PubMed ID: 22925885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional repressor functions of Drosophila E2F1 and E2F2 cooperate to inhibit genomic DNA synthesis in ovarian follicle cells.
    Cayirlioglu P; Ward WO; Silver Key SC; Duronio RJ
    Mol Cell Biol; 2003 Mar; 23(6):2123-34. PubMed ID: 12612083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A dual role for the dREAM/MMB complex in the regulation of differentiation-specific E2F/RB target genes.
    Lee H; Ragusano L; Martinez A; Gill J; Dimova DK
    Mol Cell Biol; 2012 Jun; 32(11):2110-20. PubMed ID: 22451490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell cycle-dependent and cell cycle-independent control of transcription by the Drosophila E2F/RB pathway.
    Dimova DK; Stevaux O; Frolov MV; Dyson NJ
    Genes Dev; 2003 Sep; 17(18):2308-20. PubMed ID: 12975318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of dominant-negative mutant DP-1 blocks cell cycle progression in G1.
    Wu CL; Classon M; Dyson N; Harlow E
    Mol Cell Biol; 1996 Jul; 16(7):3698-706. PubMed ID: 8668186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mosaic genetic screen for suppressors of the de2f1 mutant phenotype in Drosophila.
    Ambrus AM; Rasheva VI; Nicolay BN; Frolov MV
    Genetics; 2009 Sep; 183(1):79-92. PubMed ID: 19546319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional identification of Api5 as a suppressor of E2F-dependent apoptosis in vivo.
    Morris EJ; Michaud WA; Ji JY; Moon NS; Rocco JW; Dyson NJ
    PLoS Genet; 2006 Nov; 2(11):e196. PubMed ID: 17112319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. E2F-induced S phase requires cyclin E.
    Duronio RJ; Brook A; Dyson N; O'Farrell PH
    Genes Dev; 1996 Oct; 10(19):2505-13. PubMed ID: 8843201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant E2F activation by polyglutamine expansion of androgen receptor in SBMA neurotoxicity.
    Suzuki E; Zhao Y; Ito S; Sawatsubashi S; Murata T; Furutani T; Shirode Y; Yamagata K; Tanabe M; Kimura S; Ueda T; Fujiyama S; Lim J; Matsukawa H; Kouzmenko AP; Aigaki T; Tabata T; Takeyama K; Kato S
    Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3818-22. PubMed ID: 19237573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ORC localization in Drosophila follicle cells and the effects of mutations in dE2F and dDP.
    Royzman I; Austin RJ; Bosco G; Bell SP; Orr-Weaver TL
    Genes Dev; 1999 Apr; 13(7):827-40. PubMed ID: 10197983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.